Evidence map›Paper›PMID 36945203›Full record

ArticleJournal of quantitative spectroscopy & radiative transfer2023

Polarimetric imaging for the detection of synthetic models of SARS-CoV-2: A proof of concept.

Emilio Gomez-Gonzalez, Olga Muñoz, Juan Carlos Gomez-Martin, Jesus Aceituno-Castro, Beatriz Fernandez-Muñoz, Jose Manuel Navas-Garcia, Alejandro Barriga-Rivera, Isabel Fernandez-Lizaranzu, Francisco Javier Munoz-Gonzalez, Ruben Parrilla-Giraldez and 16 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of quantitative spectroscopy & radiative transfer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 63% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 11 institutions in 3 countries.

Emilio Gomez-GonzalezGroup of Interdisciplinary Physics, Department of Applied Physics III at the ETSI Engineering School, Universidad de Sevilla, Seville 41092, Spain.
Olga MuñozCosmic Dust Laboratory, Instituto de Astrofísica de Andalucía, CSIC, Granada 18008, Spain.
Juan Carlos Gomez-MartinCosmic Dust Laboratory, Instituto de Astrofísica de Andalucía, CSIC, Granada 18008, Spain.
Jesus Aceituno-CastroCosmic Dust Laboratory, Instituto de Astrofísica de Andalucía, CSIC, Granada 18008, Spain.
Beatriz Fernandez-MuñozUnidad de Producción y Reprogramación Celular, Red Andaluza de Diseño y Traslación de Terapias Avanzadas, Fundacion Publica Andaluza Progreso y Salud, Sevilla 41092, Spain.
Jose Manuel Navas-GarciaEOD-CBRN Group, Spanish National Police, Sevilla 41011, Spain.
Alejandro Barriga-RiveraGroup of Interdisciplinary Physics, Department of Applied Physics III at the ETSI Engineering School, Universidad de Sevilla, Seville 41092, Spain.
Isabel Fernandez-LizaranzuGroup of Interdisciplinary Physics, Department of Applied Physics III at the ETSI Engineering School, Universidad de Sevilla, Seville 41092, Spain.
Francisco Javier Munoz-GonzalezGroup of Interdisciplinary Physics, Department of Applied Physics III at the ETSI Engineering School, Universidad de Sevilla, Seville 41092, Spain.
Ruben Parrilla-GiraldezTechnology and Innovation Centre, Universidad de Sevilla, Sevilla 41012, Spain.
Desiree Requena-LancharroGroup of Interdisciplinary Physics, Department of Applied Physics III at the ETSI Engineering School, Universidad de Sevilla, Seville 41092, Spain.
Pedro Gil-GamboaGroup of Interdisciplinary Physics, Department of Applied Physics III at the ETSI Engineering School, Universidad de Sevilla, Seville 41092, Spain.
José Luis RamosCosmic Dust Laboratory, Instituto de Astrofísica de Andalucía, CSIC, Granada 18008, Spain.
Cristina Rosell-ValleUnidad de Producción y Reprogramación Celular, Red Andaluza de Diseño y Traslación de Terapias Avanzadas, Fundacion Publica Andaluza Progreso y Salud, Sevilla 41092, Spain.
Carmen Gomez-GonzalezService of Intensive Care, University Hospital 'Virgen del Rocio', Sevilla 41013, Spain.
Maria Martin-LopezUnidad de Producción y Reprogramación Celular, Red Andaluza de Diseño y Traslación de Terapias Avanzadas, Fundacion Publica Andaluza Progreso y Salud, Sevilla 41092, Spain.
Maria Isabel Relimpio-LopezDepartment of General Surgery, College of Medicine, Universidad de Sevilla, Seville 41009, Spain.
Manuel A Perales-EsteveGroup of Interdisciplinary Physics, Department of Applied Physics III at the ETSI Engineering School, Universidad de Sevilla, Seville 41092, Spain.
Antonio Puppo-MorenoInstitute of Biomedicine of Seville, Spain.
Francisco Jose Garcia-CozarDepartment of Biomedicine, Biotechnology and Public Health, University of Cadiz, Cadiz 11003, Spain.
Lucia Olvera-CollantesDepartment of Biomedicine, Biotechnology and Public Health, University of Cadiz, Cadiz 11003, Spain.
Silvia de Los Santos-TrigoCorporación Tecnológica de Andalucía, Sevilla 41092, Spain.
Emilia GomezJoint Research Centre, European Commission, Sevilla 41092, Spain.
Rosario Sanchez-PernauteUnidad de Producción y Reprogramación Celular, Red Andaluza de Diseño y Traslación de Terapias Avanzadas, Fundacion Publica Andaluza Progreso y Salud, Sevilla 41092, Spain.
Javier Padillo-RuizInstitute of Biomedicine of Seville, Spain.
Javier Marquez-RivasGroup of Interdisciplinary Physics, Department of Applied Physics III at the ETSI Engineering School, Universidad de Sevilla, Seville 41092, Spain.
Instituto de Biomedicina de Sevilla · ESUniversidad de Sevilla · ESInstituto de Astrofísica de Andalucía · ESUniversidad de Cádiz · ESCalar Alto Observatory · ESConsejería de Salud y Consumo · ESEuropean Commission · BEHospital Universitario Virgen del Rocío · ESInstituto de Salud Carlos III · ESTechnological Corporation of Andalusia · ESThe University of Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To conduct a proof-of-concept study of the detection of two synthetic models of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using polarimetric imaging. Approach: Two SARS-CoV-2 models were prepared as engineered lentiviruses pseudotyped with the G protein of the vesicular stomatitis virus, and with the characteristic Spike protein of SARS-CoV-2. Samples were prepared in two biofluids (saline solution and artificial saliva), in four concentrations, and deposited as 5-µL droplets on a supporting plate. The angles of maximal degree of linear polarization (DLP) of light diffusely scattered from dry residues were determined using Mueller polarimetry from87 samples at 405 nm and 514 nm. A polarimetric camera was used for imaging several samples under 380-420 nm illumination at angles similar to those of maximal DLP. Per-pixel image analysis included quantification and combination of polarization feature descriptors in 475 samples. Main results: The angles (from sample surface) of maximal DLP were 3° for 405 nm and 6° for 514 nm. Similar viral particles that differed only in the characteristic spike protein of the SARS-CoV-2, their corresponding negative controls, fluids, and the sample holder were discerned at 10-degree and 15-degree configurations. Significance: Polarimetric imaging in the visible spectrum may help improve fast, non-contact detection and identification of viral particles, and/or other microbes such as tuberculosis, in multiple dry fluid samples simultaneously, particularly when combined with other imaging modalities. Further analysis including realistic concentrations of real SARS-CoV-2 viral particles in relevant human fluids is required. Polarimetric imaging under visible light may contribute to a fast, cost-effective screening of SARS-CoV-2 and other pathogens when combined with other imaging modalities.

Indexed as

COVID-19Mueller polarimetryPolarimetric imagingSARS-CoV-2Virus detection

Identifiers

PMID36945203
PMCPMC9987604
OpenAlexW4323321796

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.